WO2003009882A3 - Local concentration management system - Google Patents

Local concentration management system Download PDF

Info

Publication number
WO2003009882A3
WO2003009882A3 PCT/US2002/022813 US0222813W WO03009882A3 WO 2003009882 A3 WO2003009882 A3 WO 2003009882A3 US 0222813 W US0222813 W US 0222813W WO 03009882 A3 WO03009882 A3 WO 03009882A3
Authority
WO
WIPO (PCT)
Prior art keywords
agent
elongate body
dilutor
lcms
diffuser element
Prior art date
Application number
PCT/US2002/022813
Other languages
French (fr)
Other versions
WO2003009882A2 (en
WO2003009882B1 (en
Inventor
Felix Theeuwes
Su Il Yum
Original Assignee
Durect Corp
Felix Theeuwes
Su Il Yum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Durect Corp, Felix Theeuwes, Su Il Yum filed Critical Durect Corp
Priority to AU2002320601A priority Critical patent/AU2002320601A1/en
Priority to EP02750129A priority patent/EP1418974A4/en
Publication of WO2003009882A2 publication Critical patent/WO2003009882A2/en
Publication of WO2003009882A3 publication Critical patent/WO2003009882A3/en
Publication of WO2003009882B1 publication Critical patent/WO2003009882B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • A61M2025/0057Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/105Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1086Balloon catheters with special features or adapted for special applications having a special balloon surface topography, e.g. pores, protuberances, spikes or grooves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features

Abstract

The invention provides a local concentration management system (LCMS) for delivery of highly concentrated therapeutic agent formulations. The LCMS comprises a device comprising an elongate body (20) defining a lumen (26) between its proximal (21) and distal (23) ends, and a diffuser element (30), a dilutor element (60), or both. The diffuser element, which is selectively permeable to the agent, is operatively associated with the elongate body (20) so that agent flows through the elongate body, and into and through the diffuser element to exit the system. The dilutor element can be operatively associated with the system to be in fluid communication with the elongate body lumen, a diffusion space defined by a diffuser element inner wall, or both. The dilutor element is selectively water permeable, but substantially impermeable to agent, to provide for dilution of the agent during transit through the system. The LCMS system is designed to disperse and/or dilute the drug delivery stream.
PCT/US2002/022813 2001-07-26 2002-07-16 Local concentration management system WO2003009882A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002320601A AU2002320601A1 (en) 2001-07-26 2002-07-16 Local concentration management system
EP02750129A EP1418974A4 (en) 2001-07-26 2002-07-16 Local concentration management system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/917,181 US7438701B2 (en) 2001-07-26 2001-07-26 Local concentration management system
US09/917,181 2001-07-26

Publications (3)

Publication Number Publication Date
WO2003009882A2 WO2003009882A2 (en) 2003-02-06
WO2003009882A3 true WO2003009882A3 (en) 2003-08-28
WO2003009882B1 WO2003009882B1 (en) 2003-11-20

Family

ID=25438452

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/022813 WO2003009882A2 (en) 2001-07-26 2002-07-16 Local concentration management system

Country Status (4)

Country Link
US (2) US7438701B2 (en)
EP (1) EP1418974A4 (en)
AU (1) AU2002320601A1 (en)
WO (1) WO2003009882A2 (en)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10105592A1 (en) 2001-02-06 2002-08-08 Achim Goepferich Placeholder for drug release in the frontal sinus
US7438701B2 (en) * 2001-07-26 2008-10-21 Durect Corporation Local concentration management system
US8317816B2 (en) 2002-09-30 2012-11-27 Acclarent, Inc. Balloon catheters and methods for treating paranasal sinuses
US8043281B2 (en) * 2002-12-23 2011-10-25 Medtronic, Inc. Catheters incorporating valves and permeable membranes
AU2003303387A1 (en) * 2002-12-23 2004-07-22 Medtronic, Inc. Multiple infusion section catheters, systems, and methods
US8246602B2 (en) * 2002-12-23 2012-08-21 Medtronic, Inc. Catheters with tracking elements and permeable membranes
US8105310B2 (en) * 2003-05-21 2012-01-31 Klein Jeffrey A Infiltration cannula
WO2005007223A2 (en) * 2003-07-16 2005-01-27 Sasha John Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
US8146400B2 (en) 2004-04-21 2012-04-03 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US8894614B2 (en) 2004-04-21 2014-11-25 Acclarent, Inc. Devices, systems and methods useable for treating frontal sinusitis
US8747389B2 (en) 2004-04-21 2014-06-10 Acclarent, Inc. Systems for treating disorders of the ear, nose and throat
US7419497B2 (en) 2004-04-21 2008-09-02 Acclarent, Inc. Methods for treating ethmoid disease
US10188413B1 (en) 2004-04-21 2019-01-29 Acclarent, Inc. Deflectable guide catheters and related methods
US9554691B2 (en) 2004-04-21 2017-01-31 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US20190314620A1 (en) 2004-04-21 2019-10-17 Acclarent, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US8864787B2 (en) 2004-04-21 2014-10-21 Acclarent, Inc. Ethmoidotomy system and implantable spacer devices having therapeutic substance delivery capability for treatment of paranasal sinusitis
US7462175B2 (en) 2004-04-21 2008-12-09 Acclarent, Inc. Devices, systems and methods for treating disorders of the ear, nose and throat
US7410480B2 (en) * 2004-04-21 2008-08-12 Acclarent, Inc. Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US20060063973A1 (en) 2004-04-21 2006-03-23 Acclarent, Inc. Methods and apparatus for treating disorders of the ear, nose and throat
US20070167682A1 (en) 2004-04-21 2007-07-19 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US7654997B2 (en) 2004-04-21 2010-02-02 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat
US7803150B2 (en) 2004-04-21 2010-09-28 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US8932276B1 (en) 2004-04-21 2015-01-13 Acclarent, Inc. Shapeable guide catheters and related methods
US8764729B2 (en) 2004-04-21 2014-07-01 Acclarent, Inc. Frontal sinus spacer
US20060004323A1 (en) 2004-04-21 2006-01-05 Exploramed Nc1, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US7559925B2 (en) 2006-09-15 2009-07-14 Acclarent Inc. Methods and devices for facilitating visualization in a surgical environment
US9101384B2 (en) 2004-04-21 2015-08-11 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat
US7361168B2 (en) 2004-04-21 2008-04-22 Acclarent, Inc. Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US20070208252A1 (en) 2004-04-21 2007-09-06 Acclarent, Inc. Systems and methods for performing image guided procedures within the ear, nose, throat and paranasal sinuses
US9351750B2 (en) 2004-04-21 2016-05-31 Acclarent, Inc. Devices and methods for treating maxillary sinus disease
US9089258B2 (en) * 2004-04-21 2015-07-28 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US8702626B1 (en) 2004-04-21 2014-04-22 Acclarent, Inc. Guidewires for performing image guided procedures
US9399121B2 (en) 2004-04-21 2016-07-26 Acclarent, Inc. Systems and methods for transnasal dilation of passageways in the ear, nose or throat
WO2011066577A1 (en) 2009-11-30 2011-06-03 Jeffrey Alan Klein Tumescent antibiotic solution
US11213481B2 (en) 2004-06-25 2022-01-04 Hk Pharma Tumescent drug delivery
US8364256B2 (en) * 2004-11-15 2013-01-29 Coraje, Inc. Method and apparatus of removal of intravascular blockages
US20060129126A1 (en) * 2004-11-19 2006-06-15 Kaplitt Michael G Infusion device and method for infusing material into the brain of a patient
US8951225B2 (en) 2005-06-10 2015-02-10 Acclarent, Inc. Catheters with non-removable guide members useable for treatment of sinusitis
US8801694B2 (en) 2005-08-11 2014-08-12 Massachusetts Institute Of Technology Intravesical drug delivery device
US8114113B2 (en) 2005-09-23 2012-02-14 Acclarent, Inc. Multi-conduit balloon catheter
US8190389B2 (en) 2006-05-17 2012-05-29 Acclarent, Inc. Adapter for attaching electromagnetic image guidance components to a medical device
US9820688B2 (en) 2006-09-15 2017-11-21 Acclarent, Inc. Sinus illumination lightwire device
US8439687B1 (en) 2006-12-29 2013-05-14 Acclarent, Inc. Apparatus and method for simulated insertion and positioning of guidewares and other interventional devices
US8118757B2 (en) 2007-04-30 2012-02-21 Acclarent, Inc. Methods and devices for ostium measurement
US8485199B2 (en) 2007-05-08 2013-07-16 Acclarent, Inc. Methods and devices for protecting nasal turbinate during surgery
JP5560200B2 (en) 2007-12-11 2014-07-23 マサチューセッツ インスチテュート オブ テクノロジー Implantable drug delivery device for treating bladder and other body vesicles or lumens
US10206821B2 (en) 2007-12-20 2019-02-19 Acclarent, Inc. Eustachian tube dilation balloon with ventilation path
US8182432B2 (en) 2008-03-10 2012-05-22 Acclarent, Inc. Corewire design and construction for medical devices
US9138559B2 (en) * 2008-06-16 2015-09-22 Twin Star Medical, Inc Flexible catheter
JP5676446B2 (en) 2008-07-30 2015-02-25 アクラレント インコーポレイテッド Sinus mouth finder
CA2733468C (en) 2008-08-09 2017-12-05 Massachusetts Institute Of Technology Implantable drug delivery device and methods of treating male genitourinary and surrounding tissues
EP2323724A1 (en) 2008-09-18 2011-05-25 Acclarent, Inc. Methods and apparatus for treating disorders of the ear nose and throat
US20100241155A1 (en) 2009-03-20 2010-09-23 Acclarent, Inc. Guide system with suction
US8435290B2 (en) 2009-03-31 2013-05-07 Acclarent, Inc. System and method for treatment of non-ventilating middle ear by providing a gas pathway through the nasopharynx
US7978742B1 (en) 2010-03-24 2011-07-12 Corning Incorporated Methods for operating diode lasers
ES2401007T3 (en) 2009-06-26 2013-04-16 Taris Biomedical, Inc. Implantable drug delivery devices and manufacturing procedures thereof
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
CN102946936B (en) * 2010-03-30 2016-05-04 火花医学研究有限公司 Medicine discharges medical catheter, pipe and device
ES2822118T3 (en) 2010-08-05 2021-04-29 Taris Biomedical Llc Implantable Drug Delivery Devices for Genitourinary Sites
US9155492B2 (en) 2010-09-24 2015-10-13 Acclarent, Inc. Sinus illumination lightwire device
AU2012205654B2 (en) 2011-01-10 2016-09-08 Allergan, Inc. Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
CA2825399A1 (en) 2011-02-04 2012-08-09 Taris Biomedical, Inc. Implantable device for controlled release of low solubility drug
US8702678B2 (en) * 2011-08-03 2014-04-22 Venous Therapy, Inc. Assemblies, systems, and methods for infusing therapeutic agents into the body
US8685106B2 (en) 2011-11-15 2014-04-01 Abraham Lin Method of a pharmaceutical delivery system for use within a joint replacement
EP2722070B1 (en) * 2011-12-21 2017-07-26 Fenwal, Inc. Fluid flow circuit
US9629684B2 (en) 2013-03-15 2017-04-25 Acclarent, Inc. Apparatus and method for treatment of ethmoid sinusitis
CN105163794B (en) 2013-03-15 2020-03-27 塔里斯生物医药公司 Drug delivery device and method with drug permeable member
US9433437B2 (en) 2013-03-15 2016-09-06 Acclarent, Inc. Apparatus and method for treatment of ethmoid sinusitis
IL299897B2 (en) 2013-08-19 2024-02-01 Taris Biomedical Llc Multi-unit drug delivery devices and methods
JP7425534B2 (en) 2015-04-23 2024-01-31 タリス バイオメディカル エルエルシー Drug delivery devices and methods with drug permeable components
EP3586893A1 (en) 2018-06-21 2020-01-01 Medtronic, Inc. Optimized intrathecal drug delivery
EP3593833A1 (en) 2018-07-13 2020-01-15 Medtronic Inc. Catheter for increased intrathecal drug dispersion
WO2020071546A1 (en) * 2018-10-04 2020-04-09 株式会社 メドレックス Preparation stabilized by means of nonaqueous solvent
US11672476B2 (en) 2019-09-17 2023-06-13 Medtronic, Inc. Intrathecal catheter with means to measure quality of drug dispersion
US11344714B2 (en) 2019-11-04 2022-05-31 Medtronic, Inc. Intrathecal catheter with features to reduce drug dispersion

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4437856A (en) * 1981-02-09 1984-03-20 Alberto Valli Peritoneal catheter device for dialysis

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640269A (en) * 1969-10-24 1972-02-08 Jose M R Delgado Fluid-conducting instrument insertable in living organisms
US3817248A (en) * 1972-11-06 1974-06-18 Alza Corp Self powered device for delivering beneficial agent
US4402694A (en) * 1981-07-16 1983-09-06 Biotek, Inc. Body cavity access device containing a hormone source
US5122127A (en) * 1985-05-01 1992-06-16 University Of Utah Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
US5221260A (en) * 1989-01-13 1993-06-22 Scimed Life Systems, Inc. Innerless dilatation balloon catheter
US5087244A (en) * 1989-01-31 1992-02-11 C. R. Bard, Inc. Catheter and method for locally applying medication to the wall of a blood vessel or other body lumen
US5609885A (en) 1992-09-15 1997-03-11 Alza Corporation Osmotic membrane and delivery device
US5607696A (en) 1995-02-10 1997-03-04 Alza Corporation Osmotic membrane and delivery device
US5752930A (en) * 1995-04-28 1998-05-19 Medtronic, Inc. Implantable techniques for infusing equal volumes of agents to spaced sites
US5846220A (en) * 1996-04-30 1998-12-08 Medtronic, Inc. Therapeutic method for treatment of Alzheimer's disease
US5842971A (en) * 1996-05-22 1998-12-01 Yoon; Inbae Optical endoscopic portals and methods of using the same to establish passages through cavity walls
US6500174B1 (en) * 1997-07-08 2002-12-31 Atrionix, Inc. Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US6113915A (en) * 1999-10-12 2000-09-05 Allergan Sales, Inc. Methods for treating pain
US6551290B1 (en) * 2000-03-31 2003-04-22 Medtronic, Inc. Catheter for target specific drug delivery
ATE452678T1 (en) * 2001-03-01 2010-01-15 David A Watson INGROWTH PREVENTIVE CATHETER ARRANGEMENT
US7438701B2 (en) * 2001-07-26 2008-10-21 Durect Corporation Local concentration management system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4437856A (en) * 1981-02-09 1984-03-20 Alberto Valli Peritoneal catheter device for dialysis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1418974A4 *

Also Published As

Publication number Publication date
EP1418974A4 (en) 2007-07-04
WO2003009882A2 (en) 2003-02-06
US7438701B2 (en) 2008-10-21
US20030032942A1 (en) 2003-02-13
AU2002320601A1 (en) 2003-02-17
EP1418974A2 (en) 2004-05-19
US20070167932A1 (en) 2007-07-19
WO2003009882B1 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
WO2003009882A3 (en) Local concentration management system
WO2003009883B1 (en) Catheter for modification of agent formulation
WO2005056078A3 (en) Facilitated balloon catheter exchange
WO2001080825A3 (en) Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
DE60218835D1 (en) CATHETER SYSTEM WITH SPACER
AU2003209926A1 (en) Connection element and connecting device for tubes
WO2002043750A3 (en) Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations
DE69208104D1 (en) ORAL, OSMOTIC DEVICE
ATE376851T1 (en) DEVICE FOR INTRODUCING A MEDICATION INTO THE RESPIRATORY SYSTEM
EP1138275A3 (en) Multiple solution dental irrigator
ATE422862T1 (en) STENT SYSTEM
AU9171598A (en) Guiding element for balloon catheters or the like and method of use
FR2836384B1 (en) RESPIRATORY ASSISTANCE DEVICE
PT984762E (en) DEBIT CONTROLLER CONFIGURATIONS FOR AN ACTIVE AGENT ADMINISTRATION DEVICE
AU5868400A (en) Anti-infective medical device and production method
SE0202172L (en) Device and method for circulatory isolation and treatment of body part
DK0936893T3 (en) Device with multiple flow paths for oral delivery of discrete units
WO2002047744A3 (en) Method and catheter for aerating fluids for medical uses
CN103379935B (en) For generating the method and apparatus containing nitric oxide production gas flow
BR0313193A (en) System for cleaning a patient's bowel, mouthpiece assembly; and method for cleaning a stoma
DE69938001D1 (en) BGABE OF A GAS-ENRICHED LIQUID
ATE386473T1 (en) DISPOSABLE CATHETER
SE0203590D0 (en) Medical device
ES2189639B1 (en) AQUOUS COMPOSITION CONTAINING ACETILSALICILIC ACID.
RU2001128807A (en) Method for sterilization of biological preparations with gaseous ethylene oxide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
B Later publication of amended claims

Free format text: 20030813

WWE Wipo information: entry into national phase

Ref document number: 2002750129

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002750129

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP